SHANGHAI, Dec. 3, 2021 /PRNewswire/ -- OrigiMed Co., Ltd. ("OrigiMed") announced that the company h...
* The companion diagnostic (CDx) Human Neurotrophic Tyrosine Receptor Kinase ( NTRK) 1/2/3 Genomic...